Innovating Works

ULBASA

Activa
ProCAncer-I: An AI Platform integrating imaging data and models supporting precision care through prostate cance... IDRYMA TECHNOLOGIAS KAI EREVNAS tramitó un H2020: H2020-SC1-FA-DTS-2018-2020 In Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices, of...
2020-05-29 - 2024-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.